Showing results (51-60 of 450) with videos related to
Sort By:
Pageof 45
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Beta 1-integrins on melanoma clones regulate the interaction with autologous cytolytic T-cell clonesA Anichini, R Mortarini, G ParmianiImmunology Today|October 8, 2014
Clonal analysis of the cytolytic T-cell response to human tumorsA Anichini, G Fossati, G ParmianiJournal of the National Cancer Institute|March 7, 1990
Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?G Parmiani, A Anichini, G FossatiCancer Immunology, Immunotherapy : CII|January 1, 1989
Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organsM Rodolfo, C Salvi, G ParmianiBritish Journal of Cancer|September 15, 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutationG Della Torre, B Pasini, S Frigerio, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 23, 1999
Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomasM A Pierotti, P Vigneri, I BongarzoneMolecular and Cellular Endocrinology|November 4, 2009
Rearrangements of NTRK1 gene in papillary thyroid carcinomaA Greco, C Miranda, M A PierottiCancer Immunology, Immunotherapy : CII|January 1, 1985
Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cellsM P Colombo, M Parenza, G ParmianiTumori|April 30, 1985
Genetic unresponsiveness to a murine fibrosarcoma determined by the host genetic environment but not by lymphocyte precursor genotypeM P Colombo, M Rodolfo, G ParmianiPageof 45